Labiotech.eu

News and Trends 22 Apr 2016

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

Saphetor is developing genome-scale analysis of next generation sequencing (NGS) results – and will now ‘play’ with real data of Endocrine patients at the Lausanne University Hospital. Based in Lausanne’s EPFL Innovation Park (Switzerland), Saphetor was founded only in 2014 and completed a seed financing round this February, raising around €1M (1.2M CHF). This startup develops proprietary […]

April 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Apr 2016

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

The research team led by Emannuelle Charpentier, co-discoverer of the CRISPR/Cas9 system, has found that a new CRISPR system can also cleave RNA. Amazingly simple! The discovery of the CRISPR/Cas9 system revolutionised Biotechnology, unlocking a kind of ‘Golden age’ for gene editing – with a wide-reaching impact from therapeutics to SynBio. So, it’s no wonder that […]

April 21, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 21 Apr 2016

These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting

The annual meeting of the American Association for Cancer Research (AACR) has just finished. From Europe, who made a splash with their results? The AACR annual meeting is the world’s biggest conference in Cancer research, and the must-attend event for Biotechs developing cancer therapies. The 2016 edition took place in New Orleans (US) from the […]

April 21, 2016 - 5 minutesmins - By Denise Neves Gameiro

News and Trends 21 Apr 2016

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

Ghent based argenx has just partnered up with the French AbbVie to develop a novel antibody derived from llamas – in its biggest deal ever! Having been better known for their work into autoimmune diseases, argenx has now also broken into the Immuno-Oncology field – big time. Previous collaborators have included Denmark’s Leo Pharma for inflammatory […]

April 21, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 20 Apr 2016

What’s the deal with Lactose free yogurt in Denmark?

Novozymes, the European leader for Industrial Biotech, has had a good start to 2016. It has now launched some new ideas, including for lactose-free food products. Novozymes is a giant in the production of enzymes, an important player in the ‘traditional Biotech’ biocatalysis revolution and a cornerstone in the Danish Biotech scene. The company has now released its financial […]

April 20, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 20 Apr 2016

French Biotech submits new Drug for Eye Allergies to the FDA

Nicox is filing a New Drug Application for its allergic conjuntivitis candidate, a novel eye drop formulation of a well-known antihistamine. Based in Sophia Antipolis (near the French Riviera), Nicox is developing therapies in ophthalmology. Now, it has submitted one of its candidates (AC-170) for FDA approval, after good results from two phase III trials evaluating both the safety and […]

April 20, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 19 Apr 2016

Drug Discovery moves to Stevenage – the new Golden Triangle hotspot?

MRC Technology, a UK medical research charity, has moved most of its labs to the Stevenage Bioscience Catalyst (SBC) campus. Located inside the gold triangle, is this the new hotspot of UK Biotech? MRC Technology provides drug discovery services, as well as advice for commercialisation and intellectual property management, for academia and industry. Since it was founded […]

April 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 19 Apr 2016

French Microbiome Therapy boosted by compound from major US Biotech

Enterome, a leader in the European microbiome field, has struck a deal with US’ Vertex to develop novel small molecules with potential to treat inflammatory bowel diseases. With an impressive roll of partnerships and backed by the world-first Microbiome fund, Enterome is very well-positioned in hype field of the Microbiome. We discussed Enterome’s differentiated strategy […]

April 19, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 19 Apr 2016

GSK goes to phase II with German Antibody for Inflammatory Diseases

GSK has started a phase II trial for inflammatory hand osteoarthritis, with a candidate originally from MorphoSys‘ antibody library. GSK, a big UK Pharma, has announced the start of a phase II study to evaluate the efficacy and safety of its candidate, GSK3196165. The trial will enroll 40 patients with hand osteoarthritis – a condition that damages […]

April 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

Best in Biotech 18 Apr 2016

Who are France’s Young Innovators in Biotech and Medicine this year?

The MIT Technology Review has released it’s next generation of best and brightest in French Tech. This also includes a surprising number of Biotech entrepreneurs… The 2016 cohort of French innovators under 35 will now join the ranks of many high risers in the Biotech industry, many of which have gone on to secure funding and […]

April 18, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 18 Apr 2016

UK Drug Discovery sells Cancer Target to German Pharma

Boehringer Ingelheim has bought exclusive rights to an oncology target discovered by Oxford BioTherapeutics and its proteomic database. Oxford BioTherapeutics is a Biotech in Milton Park (near Oxford, UK), developing immunotherapies for cancer with antibody-drug conjugates (ADC) – a strategy to combine the specificity of antibodies to a toxic agent that can be delivered to a cancerous cell. […]

April 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 18 Apr 2016

Very promising Results for Resistant Lung Cancer

Ariad has presented updated results of an ongoing phase I/II trial for lung cancer, scoring 100% in one-year overall survival. Ariad Pharmaceuticals is developing small molecules to treat difficult cancers, using computational and structural biology research. It is based in Cambridge (US) and Lausanne (Switzerland). One of the hard-to-treat cancers that Ariad is targeting is […]

April 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

What’s the deal with Lactose free yogurt in Denmark?

French Biotech submits new Drug for Eye Allergies to the FDA

Drug Discovery moves to Stevenage – the new Golden Triangle hotspot?

French Microbiome Therapy boosted by compound from major US Biotech

GSK goes to phase II with German Antibody for Inflammatory Diseases

Who are France’s Young Innovators in Biotech and Medicine this year?

UK Drug Discovery sells Cancer Target to German Pharma

Very promising Results for Resistant Lung Cancer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!